References
Behan PO, Chaudhuri A (2010) The sad plight of multiple sclerosis research (low on fact, high on fiction): critical data to support it being a neurocristopathy. Inflammopharmacology. Sep 24 [Epub ahead of print]
Behan PO, Chaudhuri A, Roep BO (2002) The pathogenesis of multiple sclerosis revisited. J R Coll. Physicians Edinb 32:244–265
Brown MG, Kirby S, Skedgel C et al (2007) How effective are disease-modifying drugs in delaying progression in relapsing-onset MS? Neurology 69:1498–1507
Doepp F, Paul F, Valdueza JM et al (2010) No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol 68:173–183
Frohman EM, Stüve O, Havrdova E et al (2005) Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations. Arch Neurol 62:1519–1530
Handunnetthi L, Ramagopalan SV, Ebers GC (2010) Multiple sclerosis, vitamin D, and HLA-DRB1*15. Neurology 74:1905–1910
Rodriguez M (2009) Have we finally identified an autoimmune demyelinating disease? Ann Neurol 66:572–573
Sriram S, Steiner I (2005) EAE: a misleading model for MS. Ann Neurol 58:939–945
Steiner I, Wirguin I (2000) Multiple sclerosis—in need of critical reappraisal. Med. Hypothesis 54:99–106
Sundström P, Wåhlin A, Ambarki K et al (2010) Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study. Ann Neurol 68:255–259
Zamboni P, Galeotti R, Menegatti E et al (2009) Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 80:392–399
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Steiner, I., Mosberg-Galili, R. Quo vadis multiple sclerosis?. Inflammopharmacol 18, 261–262 (2010). https://doi.org/10.1007/s10787-010-0067-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-010-0067-z